BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 32353489)

  • 21. Bacteria and sputum inflammatory cell counts; a COPD cohort analysis.
    Beech AS; Lea S; Kolsum U; Wang Z; Miller BE; Donaldson GC; Wedzicha JA; Brightling CE; Singh D
    Respir Res; 2020 Nov; 21(1):289. PubMed ID: 33131502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD.
    Dicker AJ; Crichton ML; Cassidy AJ; Brady G; Hapca A; Tavendale R; Einarsson GG; Furrie E; Elborn JS; Schembri S; Marshall SE; Palmer CNA; Chalmers JD
    Thorax; 2018 Jun; 73(6):510-518. PubMed ID: 29101284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.
    Wang Z; Singh R; Miller BE; Tal-Singer R; Van Horn S; Tomsho L; Mackay A; Allinson JP; Webb AJ; Brookes AJ; George LM; Barker B; Kolsum U; Donnelly LE; Belchamber K; Barnes PJ; Singh D; Brightling CE; Donaldson GC; Wedzicha JA; Brown JR;
    Thorax; 2018 Apr; 73(4):331-338. PubMed ID: 29269441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
    Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
    PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
    Bouquet J; Tabor DE; Silver JS; Nair V; Tovchigrechko A; Griffin MP; Esser MT; Sellman BR; Jin H
    Respir Res; 2020 Mar; 21(1):77. PubMed ID: 32228581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
    Wang J; Chai J; Sun L; Zhao J; Chang C
    BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sputum microbiota and inflammatory subtypes in asthma, COPD, and its overlap.
    Morimoto C; Matsumoto H; Nomura N; Sunadome H; Nagasaki T; Sato S; Sato A; Oguma T; Ito I; Kogo M; Tomii K; Tajiri T; Ohashi K; Tsukahara T; Hirai T
    J Allergy Clin Immunol Glob; 2024 Feb; 3(1):100194. PubMed ID: 38155860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung microbiome dynamics in COPD exacerbations.
    Wang Z; Bafadhel M; Haldar K; Spivak A; Mayhew D; Miller BE; Tal-Singer R; Johnston SL; Ramsheh MY; Barer MR; Brightling CE; Brown JR
    Eur Respir J; 2016 Apr; 47(4):1082-92. PubMed ID: 26917613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease.
    Qi YJ; Sun XJ; Wang Z; Bin YF; Li YH; Zhong XN; Bai J; Deng JM; He ZY
    Chin Med J (Engl); 2020 Mar; 133(5):542-551. PubMed ID: 32053571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study.
    Xue Q; Xie Y; He Y; Yu Y; Fang G; Yu W; Wu J; Li J; Zhao L; Deng X; Li R; Wang F; Zheng Y; Gao Z
    Sci Rep; 2023 Apr; 13(1):5715. PubMed ID: 37029178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
    Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sputum microbiome profiling in COPD: beyond singular pathogen detection.
    Ditz B; Christenson S; Rossen J; Brightling C; Kerstjens HAM; van den Berge M; Faiz A
    Thorax; 2020 Apr; 75(4):338-344. PubMed ID: 31996401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease.
    Sze MA; Dimitriu PA; Suzuki M; McDonough JE; Campbell JD; Brothers JF; Erb-Downward JR; Huffnagle GB; Hayashi S; Elliott WM; Cooper J; Sin DD; Lenburg ME; Spira A; Mohn WW; Hogg JC
    Am J Respir Crit Care Med; 2015 Aug; 192(4):438-45. PubMed ID: 25945594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the correlation between BMI and respiratory tract microbiota in acute exacerbation of COPD.
    Cao Y; Chen X; Shu L; Shi L; Wu M; Wang X; Deng K; Wei J; Yan J; Feng G
    Front Cell Infect Microbiol; 2023; 13():1161203. PubMed ID: 37180432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease.
    Tiew PY; Mac Aogáin M; Chotirmall SH
    Curr Opin Pulm Med; 2022 Mar; 28(2):121-133. PubMed ID: 34839338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short term dynamics of the sputum microbiome among COPD patients.
    Sinha R; Weissenburger-Moser LA; Clarke JL; Smith LM; Heires AJ; Romberger DJ; LeVan TD
    PLoS One; 2018; 13(3):e0191499. PubMed ID: 29518088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Airway microbiome composition correlates with lung function and arterial stiffness in an age-dependent manner.
    Lee SY; Mac Aogáin M; Fam KD; Chia KL; Binte Mohamed Ali NA; Yap MMC; Yap EPH; Chotirmall SH; Lim CL
    PLoS One; 2019; 14(11):e0225636. PubMed ID: 31770392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.
    Millares L; Pascual S; Montón C; García-Núñez M; Lalmolda C; Faner R; Casadevall C; Setó L; Capilla S; Moreno A; Castro-Acosta AA; Alvarez-Martinez CJ; Sibila O; Peces-Barba G; Cosio BG; Agustí A; Gea J; Monsó E
    BMC Pulm Med; 2019 Jun; 19(1):112. PubMed ID: 31234826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
    Tufvesson E; Bjermer L; Ekberg M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.